Efficacy of rezafungin in a case of Candida spondylodiskitis - Biology of Cardiovascular Diseases
Article Dans Une Revue Journal of Bone and Joint Infection Année : 2024

Efficacy of rezafungin in a case of Candida spondylodiskitis

Résumé

Rezafungin, which only requires weekly administration, is a potential candidate for difficult-to-treat infections that require long-term antimicrobial treatment, such as bone and joint infections. We report the first case of spondylodiskitis successfully treated with 3 weeks of caspofungin followed by 10 weeks of rezafungin.
Fichier principal
Vignette du fichier
BMC_JBJI_2024_Lahouati.pdf (986.84 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04826524 , version 1 (09-12-2024)

Licence

Identifiants

Citer

Marin Lahouati, Claire Tinévez, Frédéric Gabriel, Fabien Xuereb, Maxime Lefranc, et al.. Efficacy of rezafungin in a case of Candida spondylodiskitis. Journal of Bone and Joint Infection, 2024, 9 (5), pp.213-215. ⟨10.5194/jbji-9-213-2024⟩. ⟨hal-04826524⟩

Collections

INSERM CNRS U1034
0 Consultations
0 Téléchargements

Altmetric

Partager

More